Related Experiment Video
Updated: Jun 20, 2026

07:43
Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
11.7K
Chromatin Disruption After Prenatal Hypoxia Predicts Lasting Neuron Deficits
Biorxiv : the Preprint Server for Biology
|December 15, 2025
Summary
Prenatal hypoxia disrupts the developing brain
Area of Science:
- Neuroscience
- Developmental Biology
- Epigenetics
Background:
- Prenatal hypoxia can cause developmental disabilities by disrupting neurodevelopment.
- Epigenomic disruption is a critical consequence of prenatal hypoxia.
- Cell-type-specific effects of hypoxia on the developing brain's epigenome and transcriptome are largely unknown.
Purpose of the Study:
- To investigate the cell-type-selective effects of prenatal hypoxia on the developing brain's transcriptome and epigenome.
- To understand the mechanisms underlying lasting epigenomic changes and functional deficits after hypoxic injury.
Main Methods:
- Analysis of transcriptional and chromatin accessibility changes in various cell types immediately after hypoxia.
- Correlation of gene expression and chromatin accessibility with structural and functional deficits one month post-injury.
- Utilized a multi-omics approach to identify shared and cell-type-specific responses to hypoxia.
Main Results:
- Hypoxia causes immediate transcriptional and chromatin disruptions across all cell types.
- A selective dissociation between transcriptional and chromatin regulation was observed in glutamatergic neurons.
- Changes in chromatin accessibility, not gene expression, near specific genes correlated with long-term deficits in glutamatergic neurons.
Conclusions:
- Prenatal hypoxia induces distinct, cell-type-specific epigenomic and transcriptomic alterations in the developing brain.
- Dissociation of gene regulation in glutamatergic neurons is a key mechanism linking hypoxia to lasting functional deficits.
- These findings offer insights into the molecular basis of developmental disabilities following prenatal hypoxic injury.

